Janux Therapeutics Inc. (JANX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Janux Therapeutics Inc.

    NASDAQ: JANX · Real-Time Price · USD
    24.00
    0.69 (2.96%)
    At close: Oct 03, 2025, 3:59 PM
    24.21
    0.88%
    After-hours: Oct 03, 2025, 06:26 PM EDT

    Janux Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -41.71 -8.1 -8.66 -24.99
    PEG Ratio
    		 13.76 0.62 -0.09 -0.06
    PS Ratio
    		 271.80 58.43 63.42 223.74
    PB Ratio
    		 2.81 1.37 1.70 2.22
    P/FCF Ratio
    		 -65.15 -9.01 -11.06 -44.09
    P/OCF Ratio
    		 -65.68 -9.34 -12.72 -47.93
    OCF/S Ratio
    		 -4.14 -6.26 -4.98 -4.67
    Debt / Equity Ratio
    		 0.02 0.07 0.08 0.00
    Quick Ratio
    		 59.21 26.80 20.18 29.48
    Current Ratio
    		 59.21 26.80 20.14 29.46
    Asset Turnover
    		 0.01 0.02 0.02 0.01
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.07 -0.17 -0.2 -0.09
    Return on Assets
    		 -0.06 -0.15 -0.17 -0.09
    Return on Invested Capital
    		 -0.09 -0.2 -0.19 -0.09
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.81 0.76 0.90 0.97
    Net Profit Margin
    		 -6.52 -7.21 -7.32 -8.95
    Pretax Profit Margin
    		 -6.52 -7.21 -7.32 -8.98
    Operating Profit Margin
    		 -9.34 -9.03 -7.79 -9.05
    FCF Margin
    		 -4.17 -6.49 -5.73 -5.08
    EBITDA Margin
    		 -9.34 -8.79 -7.69 -9.02

    Add to Watchlist